Arnhem -- On 8 May an editorial about the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial by Fritz H. Schröder and Monique J. Roobol was published in the online version of European Urology , the scientific journal of the European Association of Urology (EAU).
The long-expected final report of the REDUCE trial appeared on April 1, 2010 in the New England Journal of Medicine [1] together with a commentary entitled 'Chemoprevention of prostate cancer' by Dr Patrick Walsh. What were the noteworthy items of the editorial?
References:
For more information, please contact Lindy Brouwer, EAU Communication Officer, at l.brouwer@uroweb.org .
European Urology